Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HSD11B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ASB8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDKN2D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506271 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GPR156 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MORF4L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF358 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGLJ3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUOXA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFRA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYBA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBLL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OBP2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929036 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on